Hanrahan Jessie 4
4 · Solid Biosciences Inc. · Filed Feb 6, 2026
Research Summary
AI-generated summary of this filing
Solid Biosciences (SLDB) CRO Jessie Hanrahan Sells 12,348 Shares
What Happened
- Jessie Hanrahan, Chief Regulatory Officer of Solid Biosciences (SLDB), sold 12,348 shares on 2026-02-04. The weighted-average sale price was $6.44 per share, generating approximately $79,545 in proceeds. This was a sale (not a purchase) and appears to be routine sell-to-cover activity rather than a discretionary market-timing trade.
Key Details
- Transaction date: February 4, 2026; Form 4 filed February 6, 2026 (timely filing).
- Sale type/code: S (sale) — sell-to-cover to satisfy tax withholding after RSU vesting.
- Price: weighted average $6.44; actual trades executed across a range of $6.28 to $6.60.
- Proceeds: ~$79,545.
- Shares owned after the transaction: not specified in the provided filing excerpt.
- Footnotes: The sale was effected under a durable automatic sell-to-cover instruction adopted by Dr. Hanrahan on August 16, 2024 and was not a discretionary trade. The filing notes the weighted-average price and offers to provide a breakdown of shares sold at each price on request.
Context
- This was a tax-withholding sale following the vesting of restricted stock units (RSUs). Such sell-to-cover transactions are common and typically reflect withholding requirements rather than a statement about the insider’s view on the company’s stock.
Insider Transaction Report
Form 4
Hanrahan Jessie
Chief Regulatory Officer
Transactions
- Sale
Common Stock
[F1][F2]2026-02-04$6.44/sh−12,348$79,545→ 70,327 total
Footnotes (2)
- [F1]This sale was made to cover withholding taxes following the vesting of previously granted restricted stock units pursuant to a durable automatic sale instruction letter adopted by Dr. Hanrahan on August 16, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Dr. Hanrahan.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.28 to $6.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form.
Signature
/s/ Kimberly Cornwell as attorney-in-fact for Jessie Hanrahan|2026-02-06